The transgenic expression of human CD39 on murine islets inhibits clotting of human blood

Transplantation

Volumn 82, Issue 3, 2006, Pages 428-432

  Dwyer, Karen M ^a   Mysore, Tharun B ^a   Crikis, Sandra ^a   Robson, Simon C ^b   Nandurkar, Harshal ^a   Cowan, Peter J ^a   D'Apice, Anthony J F ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anticoagulation; Human CD39; Islet cell transplantation; Xenotransplantation

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; NUCLEOSIDE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CONTROLLED STUDY; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOSIS; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; APYRASE; BLOOD COAGULATION; GENE EXPRESSION; HUMANS; ISLETS OF LANGERHANS; MICE; MICE, TRANSGENIC;

EID: 33747115379     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000229023.38873.c0     Document Type: Article

References (23)

1. Cowan PJ, Aminian A, Barlow H, et al. Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantation. Am J Transplant 2002; 2: 520.
2. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360: 2039.
3. Bennet W, Sundberg B, Lundgren T, et al. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000; 69: 711.
4. Bennet W, Groth CG, Larsson R, et al. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci 2000; 105: 125.
5. Van Deijnen JH, van Suylichem PT, Wolters GH, van Schilfgaarde R. Distribution of collagens type I, type III and type V in the pancreas of rat, dog, pig and man. Cell Tissue Res 1994; 277: 115.
6. van Suylichem PT, van Deijnen JE, Wolters GH, van Schilfgaarde R. Amount and distribution of collagen in pancreatic tissue of different species in the perspective of islet isolation procedures. Cell Transplant 1995; 4: 609.
7. Goto M, Johansson H, Maeda A, et al. Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets. Transplantation 2004; 77: 741.
8. Kaczmarek E, Koziak K, Sevigny J, et al. Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 1996; 271: 33116.
9. Goepfert C, Imai M, Brouard S, et al. CD39 modulates endothelial cell activation and apoptosis. Mol Med 2000; 6: 591.
10. Dwyer KM, Robson SC, Nandurkar HH, et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004; 113: 1440.
11. Wang TF, Guidotti G. CD39 is an ecto-(Ca2+,Mg2+)-apyrase. J Biol Chem 1996; 271: 9898.
12. Thomas HE, Darwiche R, Corbett JA, Kay TW. Interleukin-1 plus gamma interferon-induced pancreatic beta-cell dysfunction is mediated by betacell nitric oxide production. Diabetes 2002; 51: 311.
13. Imai M, Kaczmarek E, Koziak K, et al. Suppression of ATP diphosphohydrolase/CD39 in human vascular endothelial cells. Biochemistry 1999; 38: 13473.
14. Hillaire-Buys D, Chapal J, Bertrand G, et al. Purinergic receptors on insulin-secreting cells. Fundam Clin Pharmacol 1994; 8: 117.
15. Loubatieres-Mariani MM, Chapal J. Purinergic receptors involved in the stimulation of insulin and glucagon secretion. Diabete Metab 1988; 14: 119.
16. Tang J, Pugh W, Polonsky KS, Zhang H. Preservation of insulin secretory responses to P2 purinoceptor agonists in Zucker diabetic fatty rats. Am J Physiol 1996; 270: E504.
17. Polonsky KS, Semenkovich CF. The pancreatic beta cell heats up: UCP2 and insulin secretion in diabetes. Cell 2001; 105: 705.
18. Zhang CY, Baffy G, Perret P, et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001; 105: 745.
19. Enjyoji K, Sevigny J, Lin Y, et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 1999; 5: 1010.
20. Chan CB, De LD, Joseph JW, et al. Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 2001; 50: 1302.
21. Chan CB, MacDonald PE, Saleh MC, et al. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 1999; 48: 1482.
22. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710.
23. Badet L, Titus T, Metzen E, et al. The interaction between primate blood and mouse islets induces accelerated clotting with islet destruction. Xenotransplantation 2002; 9: 91.